David A. Siegel Epizyme, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$0.42 - $1.48 $159,306 - $561,364	-379,300 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.06 - $2.68 $67,734 - $171,252	63,900 Added 20.26%	379,300 $436,000
Q4 2021 Feb 14, 2022	BUY	$2.5 - $5.19 $788,500 - $1.64 Million	315,400 New	315,400 $789,000
Q2 2021 Aug 16, 2021	SELL	$6.81 - $9.71 $141,648 - $201,968	-20,800 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.45 - $12.32 $10,430 - $17,248	1,400 Added 7.22%	20,800 $181,000
Q4 2020 Feb 16, 2021	SELL	$10.34 - $13.77 $1.58 Million - $2.1 Million	-152,800 Reduced 88.73%	19,400 $211,000
Q3 2020 Nov 16, 2020	BUY	$11.73 - $16.25 $1.16 Million - $1.61 Million	99,100 Added 135.57%	172,200 $2.05 Million
Q2 2020 Aug 14, 2020	BUY	$13.68 - $20.46 $1 Million - $1.5 Million	73,100 New	73,100 $1.17 Million
Q1 2019 May 15, 2019	SELL	$5.98 - $13.98 $74,152 - $173,352	-12,400 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$5.22 - $10.44 $64,728 - $129,456	12,400 New	12,400 $76,000

About Epizyme, Inc.

Ticker EPZM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 168,364,992
Market Cap $247M

More about EPZM

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.